MN HF1246 | 2019-2020 | 91st Legislature

Status

Spectrum: Slight Partisan Bill (Democrat 23-10)
Status: Introduced on February 14 2019 - 25% progression
Action: 2019-05-13 - Author added Hornstein
Pending: House Health and Human Services Finance Committee
Text: Latest bill text (Engrossed) [PDF]

Summary

Prescription Drug Price Transparency Act established, and report required.

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription Drug Price Transparency Act established, and report required.

Sponsors


History

DateChamberAction
2019-05-13HouseAuthor added Hornstein
2019-04-10HouseAuthor added Moller
2019-04-03HouseAuthor added Sandstede
2019-03-18HouseReferred by Chair to Health and Human Services Finance Division
2019-03-18HouseCommittee report, to adopt and re-refer to Ways and Means
2019-03-11HouseCommittee report, to adopt and re-refer to Judiciary Finance and Civil Law Division
2019-03-04HouseCommittee report, to adopt as amended and re-refer to Health and Human Services Policy
2019-02-27HouseMotion to recall and re-refer, motion prevailed Commerce
2019-02-18HouseAuthors added Munson and Xiong, J.
2019-02-14HouseIntroduction and first reading, referred to Health and Human Services Policy

Same As/Similar To

SF1098 (Similar To) 2019-03-27 - Comm report: To pass as amended and re-refer to Judiciary and Public Safety Finance and Policy

Minnesota State Sources


Bill Comments

feedback